Invasive nosocomial aspergillosis associated with heart failure and complete heart block following recovery from dengue shock syndrome

Pediatric Critical Care Medicine

Volumn 8, Issue 4, 2007, Pages 389-391

  Kohli, Utkarsh ^a   Sahu, Jitendra ^a   Lodha, Rakesh ^a   Agarwal, Nidhi ^a   Ray, Ruma ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Heart block; Immunocompetent; Invasive aspergillosis

Indexed keywords

AMPHOTERICIN B; CEFTRIAXONE; DOBUTAMINE; DOPAMINE; HYDROCORTISONE; RINGER LACTATE SOLUTION;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CASE REPORT; CONGESTIVE HEART FAILURE; DENGUE; DOPPLER ECHOGRAPHY; DYSPNEA; FEVER; FUNGEMIA; FUNGUS HYPHAE; HEART BLOCK; HEART MUSCLE BIOPSY; HUMAN; HYPOTENSION; IMMUNOCOMPETENCE; INTENSIVE CARE UNIT; KIDNEY BIOPSY; KIDNEY VEIN THROMBOSIS; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; TACHYCARDIA; TERTIARY HEALTH CARE; THORAX RADIOGRAPHY;

EID: 34447305507     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000269397.95479.3C     Document Type: Article

References (15)

1. Cornet M, Mallat H, Somme D, et al: Fulminant invasive pulmonary aspergillosis in immunocompetent patients - A two-case report. Clin Microbiol Infect 2003; 9:1224-1227
2. Rouby Y, Combourieu E, Perrier-Gros-Claude JD, et al: A case of aspergillus myocarditis associated with septic shock. J Infect 1998; 37:295-297
3. Anonymous: Clinical diagnosis. In: Dengue Haemorrhagic Fever, Diagnosis, Treatment, Prevention and Control. Second Edition. Geneva, World Health Organization, 1997, pp 12-23
4. Nimmannitya S: Clinical manifestations of dengue/dengue hemorrhagic fever. In: Monograph on Dengue/Dengue Hemorrhagic Fever. New Delhi, World Health Organization, 1993, pp 48-54
5. Perfect JR, Cox GM, Lee JY, et al: The impact of culture isolation of Aspergillus species: A hospital based survey of aspergillosis. Clin Infect Dis 2001; 33:1824-1833
6. Herbrecht R, Denning DW, Patterson TF, et al: Variconazole versus Ampho B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-415
7. Richardson MD: Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005; 56(Suppl 1):i5-i11
8. Steinbach WJ: Pediatric aspergillosis: Disease and treatment differences in children. Pediatr Infect Dis J 2005; 24:358-364
9. Williams AH: Aspergillus myocarditis. Am J Clin Path 1974; 61:247-256
10. Rogers JG, Windle JR, McManus BM, et al: Aspergillus myocarditis presenting as myocardial infarction with complete heart block. Am Heart J 1990; 120:430-432
11. Yamada K, Mori T, Irie S, et al: Systemic aspergillosis caused by an aflatoxin-producing strain of Aspergillus in a post-bone marrow transplant patient with acute myeloid leukemia. Rinsho Ketsueki 1998; 39:1103-1108
12. Liu CC, Huang KJ, Lin YS, et al: Transient CD4/CD8 ratio inversion and aberrant immune activation during dengue virus infection. J Med Virol 2002; 68:241-252
13. Watt G, Kantipong P, Jongsakul K: Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin Infect Dis 2003; 36:1067-1069
14. Mori T, Matsumura M, Yamada K, et al: Systemic aspergillosis caused by an aflatoxinproducing strain of Aspergillus flavus. Med Mycol 1998; 36:107-112
15. Naithani R, Kumar R: Voriconazole. Indian Pediatr 2005; 42:1207-1212